Vidac Pharma Holding (STU:T9G) FCF Margin %: 0.00% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:T9G Vidac Pharma Holding PLC STU:T9G
21 GF Score
Price €0.41
! 2 Warning Signs
View Full Analysis

What is Vidac Pharma Holding FCF Margin %?

Vidac Pharma Holding STU:T9G -2.38% 21 FCF Margin % is 0.00% as of Jun. 2025. GuruFocus rates STU:T9G with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 954 Biotechnology companies, Vidac Pharma Holding ranks worse than 104821.7% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vidac Pharma Holding's Free Cash Flow for the six months ended in Jun. 2025 was €-0.75 Mil. Vidac Pharma Holding's Revenue for the six months ended in Jun. 2025 was €0.00 Mil. Therefore, Vidac Pharma Holding's FCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, Vidac Pharma Holding's current FCF Yield % is -5.44%.

The historical rank and industry rank for Vidac Pharma Holding's FCF Margin % or its related term are showing as below:


STU:T9G's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.885
* Ranked among companies with meaningful FCF Margin % only.

Vidac Pharma Holding FCF Margin % Related Terms

Vidac Pharma Holding FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vidac Pharma Holding's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vidac Pharma Holding FCF Margin % Chart

Vidac Pharma Holding Annual Data
Trend Dec21 Dec22 Dec23 Dec24
FCF Margin %
0.00 0.00 0.00 0.00

Vidac Pharma Holding Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

STU:T9G vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, Vidac Pharma Holding's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vidac Pharma Holding FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vidac Pharma Holding's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vidac Pharma Holding's FCF Margin % falls into.


STU:T9G
21GF Score
Vidac Pharma Holding PLC STU:T9G
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vidac Pharma Holding FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vidac Pharma Holding's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.896/0
= %

Vidac Pharma Holding's FCF Margin for the quarter that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.745/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Vidac Pharma Holding (STU:T9G) has a FCF Margin % of 0.00% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vidac Pharma Holding and its competitors. According to the industry distribution chart, Vidac Pharma Holding ranks #999999 out of 954 companies in the Biotechnology industry.
Is Vidac Pharma Holding's FCF Margin % too high?
Vidac Pharma Holding's current FCF Margin % is 0.00%. Based on the distribution chart, Vidac Pharma Holding ranks #999999 out of 954 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vidac Pharma Holding has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Vidac Pharma Holding's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vidac Pharma Holding ranks #999999 out of 954 companies for FCF Margin %. This places Vidac Pharma Holding in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vidac Pharma Holding and its competitors. Vidac Pharma Holding's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vidac Pharma Holding stock overvalued right now?
Vidac Pharma Holding (STU:T9G) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Vidac Pharma Holding's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vidac Pharma Holding (STU:T9G), the current FCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vidac Pharma Holding Business Description

Other Exchanges T9G:Germany
Address 20-22 Wenlock Road, London, GBR, N1 7GU
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company that focuses on discovering and developing medicines for oncologic and onco-dermatologic diseases. The company's research targets the modification of the tumor microenvironment to inhibit cancer cell growth by selectively affecting metabolic checkpoints in cancer cells without harming normal tissue. Its drug pipeline includes candidates such as VDA-1102 ointment, VDA-1102 IV, and VDA-1275, which are designed to treat conditions like Actinic Keratosis and Cutaneous T-cell Lymphoma. Vidac Pharma operates internationally with headquarters in London and aims to treat cancer through novel chemical entities.
21GF Score

Get the complete analysis for STU:T9G

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.41
Price